358 related articles for article (PubMed ID: 31919007)
1. Impact of the RESPOND Toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge.
Irwin AN; Novak K; Alley L; Havlin T; O'Kane N; Johnston K; Hildebran C; Carson J; Hartung DM
J Am Pharm Assoc (2003); 2020; 60(3):450-455.e3. PubMed ID: 31919007
[TBL] [Abstract][Full Text] [Related]
2. Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists.
Alley L; Novak K; Havlin T; Irwin AN; Carson J; Johnston K; O'Kane N; Hartung DM
Res Social Adm Pharm; 2020 Oct; 16(10):1422-1430. PubMed ID: 31953112
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.
Muzyk A; Smothers ZPW; Collins K; MacEachern M; Wu LT
Subst Abus; 2019; 40(4):476-483. PubMed ID: 31418645
[No Abstract] [Full Text] [Related]
4. Independent community pharmacists' attitudes and intentions toward dispensing buprenorphine/naloxone for opioid use disorder.
Zalmai R; Hill LG; Loera LJ; Mosgrove Q; Brown C
J Am Pharm Assoc (2003); 2023; 63(5):1558-1565.e4. PubMed ID: 37331654
[TBL] [Abstract][Full Text] [Related]
5. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
Thornton JD; Lyvers E; Scott VGG; Dwibedi N
J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
[TBL] [Abstract][Full Text] [Related]
6. Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.
Eukel HN; Skoy E; Werremeyer A; Burck S; Strand M
J Contin Educ Health Prof; 2019; 39(1):7-12. PubMed ID: 30614959
[TBL] [Abstract][Full Text] [Related]
7. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
Strand MA; Eukel H; Burck S
Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
[TBL] [Abstract][Full Text] [Related]
9. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis.
Salwan A; Hagemeier NE; Tudiver F; Dowling-McClay K; Foster KN; Arnold J; Alamian A; Pack RP
J Am Pharm Assoc (2003); 2020; 60(6):e173-e178. PubMed ID: 32669219
[TBL] [Abstract][Full Text] [Related]
11. Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists.
Thompson EL; Rao PSS; Hayes C; Purtill C
J Pharm Pract; 2019 Aug; 32(4):412-421. PubMed ID: 29478362
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
Riley TB; Alemagno S
Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
[TBL] [Abstract][Full Text] [Related]
13. Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication.
Hagemeier NE; Murawski MM; Lopez NC; Alamian A; Pack RP
Res Social Adm Pharm; 2014; 10(3):562-75. PubMed ID: 23981913
[TBL] [Abstract][Full Text] [Related]
14. Public attitudes and beliefs about Virginia community pharmacists dispensing and administering naloxone.
Haggerty LC; Gatewood SS; Goode JKR
J Am Pharm Assoc (2003); 2018; 58(4S):S73-S77.e1. PubMed ID: 30006189
[TBL] [Abstract][Full Text] [Related]
15. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM; Sherman EM; Shafiq S; Hardigan P
J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' attitudes, knowledge, utilization, and outcomes involving prescription drug monitoring programs: A brief scoping review.
Johnston K; Alley L; Novak K; Haverly S; Irwin A; Hartung D
J Am Pharm Assoc (2003); 2018; 58(5):568-576. PubMed ID: 30030040
[TBL] [Abstract][Full Text] [Related]
17. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional national survey of community pharmacy staff: Knowledge and antibiotic provision.
Zawahir S; Lekamwasam S; Aslani P
PLoS One; 2019; 14(4):e0215484. PubMed ID: 31022197
[TBL] [Abstract][Full Text] [Related]
19. Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse.
Fleming ML; Bapat SS; Varisco TJ
Res Social Adm Pharm; 2019 Aug; 15(8):992-999. PubMed ID: 30442574
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, Perceptions and Attitudes toward Chronic Pain and Its Management: A Cross-Sectional Survey of Frontline Pharmacists in Ontario, Canada.
Patel T; Chang F; Mohammed HT; Raman-Wilms L; Jurcic J; Khan A; Sproule B
PLoS One; 2016; 11(6):e0157151. PubMed ID: 27270723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
